US › Healthcare

Utah Medical Products Inc (UTMD)

US · Healthcare · Medical Instruments & Supplies

$74.51-0.55%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$8.5M

Revenue YoY

-14.3%

Net profit

$2.7M

Profit YoY

-11.9%

EPS

$0.84

Net margin

31.5%

Key statistics

Market cap

$236.5M

P/E

22.7

Forward P/E

13.0

P/B

1.96

Book value

$38.34

EPS (TTM)

$3.28

Dividend yield

1.65%

52-week high

$76.89

52-week low

$52.65

50-day MA

$72.72

200-day MA

$67.36

Beta

0.39

Shareholding

Insiders

7.18%

Institutions

76.62%

Largest institutional holders

Fund	Stake
Brandes Investment Partners & Co	14.97%
BlackRock Inc	6.42%
Dimensional Fund Advisors, Inc.	6.26%
Renaissance Technologies Corp	5.54%
Vanguard Capital Management, LLC	4.24%
Geode Capital Management, LLC	3.40%
Minerva Advisors LLC	2.95%
Hotchkis & Wiley Capital Management LLC	2.69%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Utah Medical Products Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.